Aadi Bioscience Inc
NASDAQ:AADI 10:26:55 AM EDT
| Market Cap (Intraday) | 43.95M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.88 |
| 50-Day MA | $2.05 |
| 200-Day MA | $3.76 |
Aadi Bioscience Inc Stock, NASDAQ:AADI
17383 Sunset Boulevard, Suite A250, Los Angeles, California 90272
United States of America
Phone: +1.424.473.8055
Number of Employees: 89
Description
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.